Skip to main content
. 2019 Dec 23;9(12):e032795. doi: 10.1136/bmjopen-2019-032795

Table 4.

Change scores for the IPSS by PGI-I outcomes

PGI-I outcome Moderate symptoms (n=88) Severe symptoms (n=73)
N (%) Change Missing N (%) Change
Very much better 3 (3.4) 6.5 (−50.7 to 63.7) 1 3 (4.1) 18 (1.7 to 34.3)
Much better 30 (34.1) 5.6 (3.7 to 7.5) 1 19 (26.0) 13.5 (10.5 to 16.5)
A little better 33 (37.5) 3.2 (1.7 to 4.8) 0 32 (43.8) 7.1 (5.3 to 9.0)
No change 19 (21.6) 1.3 (−1.7 to 4.3) 0 19 (26.0) 4.9 (2.3 to 7.6)
A little worse 3 (3.4) −5.0 (−31.0 to 20.9) 0 0 (0.0)

These results are stratified by baseline symptom severity on the IPSS: moderate symptoms are scores of 8–19 and severe symptoms are scores of ≥20. Change in IPSSs were estimated by comparing symptom scores between baseline and 6 weeks. Mean change and 95% CIs are presented. Outcomes are inverted so that positive changes reflect symptom improvement. The PGI-I category ‘a little better’ reflects the MID for both questionnaires. None of the participants scored ‘much worsened’ or ‘very much worsened’ on the PGI-I.

IPSS, International Prostate Symptom Score; MID, minimal important difference; OAB-q SF, Overactive Bladder Questionnaire short form; PGI-I, Patient Global Impression of Improvement.